Vaccines

>

Latest News

Weekly review: Clesrovimab for RSV approved, new dupilumab data, and more
Weekly review: Clesrovimab for RSV approved, new dupilumab data, and more

June 13th 2025

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Bavarian Nordic initiates trial of chikungunya vaccine in children aged 2-11 years | Image Credit: © ImageKing - © ImageKing - stock.adobe.com.
Bavarian Nordic initiates trial of chikungunya vaccine in children aged 2-11 years

June 13th 2025

Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention

June 10th 2025

Six-month IXCHIQ chikungunya vaccine data demonstrates sustained antibody levels | Image Credit: © Monir - © Monir - stock.adobe.com.
Six-month IXCHIQ chikungunya vaccine data demonstrates sustained antibody levels

June 5th 2025

County-level data set reveals widespread decline in MMW vaccination rates in the United States | Image Credit: © Leigh Prather  - © Leigh Prather - stock.adobe.com.
County-level data set reveals widespread decline in MMR vaccination rates in the United States

June 4th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.